Warner Chilcott and Sanofi-Aventis have amended their Actonel global collaboration agreement regarding the U.S. and Puerto Rico. Warner Chilcott will take full operational control for the promotion, marketing and R&D decisions for Actonel in the U.S. and PR, and will assume responsibility for all related costs. Warner Chilcott previously shared these costs with SA in these territories. In return, SA will receive collaboration payments based on U.S. and PR sales for the remainder of the colla...